Tag: Ceapro

August 27, 2019

Ceapro Announces Research Funding Award

Ceapro (TSXV:CZO) has announced that the Canadian Institutes of Health Research (CIHR) together with the Natural Sciences and Engineering Research...
June 3, 2019

Ceapro Starts Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent

Ceapro (TSXV:CZO) has announced it has started patient enrollment in its comparison study testing high-medium molecular weight beta glucan as...
November 21, 2018

Ceapro Reports 2018 Third Quarter and Nine-Month Financial Results and Operational Highlights

Ceapro (TSXV:CZO) a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced...
April 20, 2018

Ceapro Reports 2017 Financial Results

Ceapro (TSXV:CZO) a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced...
August 18, 2017

Ceapro Reports Q2 2017 Financial Results

Ceapro shared its financial results for the second quarter of 2017 and gave a business update to shareholders.
May 17, 2017

Ceapro Shares Financials for Q1 2017

Ceapro released their financial report for the first quarter of 2017 and gave a corporate update to shareholders.
May 4, 2017

Ceapro Posts Successful Findings in New Study

Ceapro announced a successful first step on a project of two studies set to investigate a water soluble solid nanodispersion...